Login / Signup

Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model.

Kevin A GuttenplanMaya K WeigelDrew I AdlerJulien CouthouisShane A LiddelowAaron D GitlerBen A Barres
Published in: Nature communications (2020)
Reactive astrocytes have been implicated in the pathogenesis of neurodegenerative diseases, including a non-cell autonomous effect on motor neuron survival in ALS. We previously defined a mechanism by which microglia release three factors, IL-1α, TNFα, and C1q, to induce neurotoxic astrocytes. Here we report that knocking out these three factors markedly extends survival in the SOD1G93A ALS mouse model, providing evidence for gliosis as a potential ALS therapeutic target.
Keyphrases
  • amyotrophic lateral sclerosis
  • mouse model
  • rheumatoid arthritis
  • signaling pathway
  • inflammatory response
  • single cell
  • stem cells
  • spinal cord
  • risk assessment
  • spinal cord injury
  • bone marrow
  • human health
  • climate change